Funding Rounds
Heartseed

Heartseed Series B round, November 2019

Heartseed

Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $26.00M

Raised Date: 2019-11-22